Get started
RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPARECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPARECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA

RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

RER1 chart


Full chart

RER1 upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪10.71 B‬ EUR
Dividend yield (indicated)
2.36%
Price to earnings Ratio (TTM)
25.61
Basic EPS (TTM)
2.05 EUR
Net income (FY)
‪389.21 M‬ EUR
Revenue (FY)
‪2.08 B‬ EUR
Shares float
‪96.65 M‬
Beta (1Y)
0.61

Employees


Employees (FY)
‪4.46 K‬
Change (1Y)
+86 +1.97%
Revenue / Employee (1Y)
‪515.90 K‬ EUR
Net income / Employee (1Y)
‪96.43 K‬ EUR

About RECORDATI ORD


Sector
Health Technology
CEO
Robert Koremans
Headquarters
Milan
Website
recordati.it
Founded
1996
ISIN
IT0003828271
FIGI
BBG000BTJSH3
Recordati SpA engages in the research, development, manufacture, and marketing of pharmaceuticals. It operates through the Specialty and Primary Care, and Rare Diseases segments. The Specialty and Primary Care segment includes pharmaceutical chemical operations. The company was founded by Giovanni Recordati in 1926 and is headquartered in Milan, Italy.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

RER1 news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of RER1 is 51.10 EUR — it has decreased by −1.35% in the past 24 hours. Watch RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA stocks are traded under the ticker RER1.
RER1 stock has fallen by −1.06% compared to the previous week, the month change is a −3.21% fall, over the last year RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA has showed a 13.30% increase.
We've gathered analysts' opinions on RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA future price: according to them, RER1 price has a max estimate of 63.00 EUR and a min estimate of 48.00 EUR. Watch RER1 chart and read a more detailed RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA stock forecast: see what analysts think of RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA and suggest that you do with its stocks.
RER1 reached its all-time high on Aug 23, 2021 with the price of 58.53 EUR, and its all-time low was 5.07 EUR and was reached on May 16, 2012. View more price dynamics on RER1 chart.
See other stocks reaching their highest and lowest prices.
RER1 stock is 1.76% volatile and has beta coefficient of 0.61. Track RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA stock price on the chart and check out the list of the most volatile stocks — is RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA there?
Today RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA has the market capitalization of ‪10.73 B‬, it has decreased by −1.35% over the last week.
Yes, you can track RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA financials in yearly and quarterly reports right on TradingView.
RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA is going to release the next earnings report on Feb 20, 2025. Keep track of upcoming events with our Earnings Calendar.
RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA revenue for the last quarter amounts to ‪557.40 M‬ EUR, despite the estimated figure of ‪558.40 M‬ EUR. In the next quarter, revenue is expected to reach ‪575.80 M‬ EUR.
RER1 net income for the last quarter is ‪113.03 M‬ EUR, while the quarter before that showed ‪101.78 M‬ EUR of net income which accounts for 11.06% change. Track more RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA financial stats to get the full picture.
RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA dividend yield was 2.46% in 2023, and payout ratio reached 63.40%. The year before the numbers were 2.97% and 75.69% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 16, 2024, the company has ‪4.46 K‬ employees. See our rating of the largest employees — is RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA EBITDA is ‪793.18 M‬ EUR, and current EBITDA margin is 34.02%. See more stats in RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA financial statements.
Like other stocks, RER1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA stock shows the buy signal. See more of RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.